Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Steven Wilson

Urology Indio, CA Medical Doctor

NPI 1043211675 CMS profile 421415

81719 Dr Carreon Blvd, Pod C, Indio, CA 92201

Open in the dashboard

General payments

$1,129,681

357 records reported · program years 2019–2024

Research payments

$1,500

Paid to them · 1 record reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Steven Wilson of Indio, CA is reported in the CMS Open Payments database as having received $1,129,681 across 357 general payments and $1,500 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Urology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $362 3
2023 General $132,431 7
2022 General $136,276 39
2021 General $249,133 101
2020 General $228,018 67
2019 General $383,461 140
2019 Research $1,500 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Steven Wilson
  • Urology median
  • Middle half of Urology
  • National median

In program year 2025, general payments to Steven Wilson were reported at $0. Among 9,461 Urology profiles paid that year, the median was $629 and the middle half received between $190 and $1,620.

Show as a table
Year Steven Wilson Urology median Middle half National median
2019 $383,461 $480 $147–$1,201 $163
2020 $228,018 $246 $87–$645 $114
2021 $249,133 $358 $111–$1,000 $132
2022 $136,276 $476 $143–$1,263 $149
2023 $132,431 $560 $168–$1,461 $160
2024 $362 $563 $170–$1,464 $164
2025 $0 $629 $190–$1,620 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Coloplast Corp $770,270 327 payments
  2. Rigicon,Inc. $230,490 3 payments
  3. Applied Medical Technology Inc $127,921 7 payments
  4. Boston Scientific Corporation $481 9 payments
  5. Innovation Technologies Inc $290 2 payments
  6. Rochester Medical Corporation $52 3 payments
  7. Antares Pharma, Inc. $50 1 payment
  8. Astellas Pharma US Inc $46 1 payment
  9. Hollister Incorporated $27 1 payment
  10. Urocure LLC $23 1 payment
  11. Other $31 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Education $499,647 81 payments
  2. Consulting Fee $430,439 34 payments
  3. Royalty or License $127,921 7 payments
  4. Travel and Lodging $59,565 76 payments
  5. Food and Beverage $12,023 158 payments
  6. Gift $88 1 payment
Products named General payments · program years 2019–2024
  1. TITAN Penile Reconstruction $529,632 180 payments
  2. Titan Men's Health $239,148 128 payments
  3. Rigi10 Malleable Penile Prosthesis Penile Implants $132,071 2 payments
  4. RIGI10 MALLEABLE PENILE PROSTHESIS Erectile Dysfunction $98,419 1 payment
  5. Scrotal Pack $80,199 4 payments
  6. TLC Kit $47,722 3 payments
  7. PENILE & TESTICULAR RECONSTRUCTN $1,178 15 payments
  8. Irrisept $290 2 payments
  9. TOROSA $213 3 payments
  10. AMS 700 $162 2 payments
  11. Other $420 12 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2024
  1. Coloplast Corp $1,500 1 payment

Records

358 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Urology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record